The archive
Every finding, one permanent page each, by day.
2026-08-10
The day's sweep is dominated by diabetes and heart drugs being tested for the kidneys. A large review found GLP-1 drugs appear safe for people with kidney failure, and a pooled analysis of three big trials showed semaglutide helps protect the kidneys. Several new trials also opened, including tests of empagliflozin and orforglipron in people — and children — with kidney disease.